CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Open-market sale Chief Financial Officer sold 1,705 shares at an average $73.16 ($124,744)
- 4 Grant or award Chief Science Officer acquired 17,371 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 5,543 shares at an average $72.54 ($402,064)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 2,313 shares at an average $71.83 ($166,136)
- 4 Open-market sale Chief Human Resources Officer sold 1,367 shares at an average $71.43 ($97,641)
- 4 Open-market sale Chief Operating Officer sold 3,870 shares at an average $71.78 ($277,797)
- 4 Open-market sale Chief Development Officer sold 1,485 shares at an average $72.97 ($108,359)
- 4 Grant or award Chief Science Officer acquired 35 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 80 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 55 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 46 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 31 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 75 shares (grant or award)
- 4 Open-market sale Chief Human Resources Officer sold 3,951 shares at an average $76.00 ($300,263)
- 4 Open-market buy Chief Executive Officer bought 4,974 shares at an average $102.44 ($509,539)
- 4 Open-market sale Chief Financial Officer sold 209 shares at $107.28 ($22,421)
- 4 Open-market sale Chief Development Officer sold 540 shares at $138.23 ($74,645)
- 4 Open-market sale Chief Financial Officer sold 828 shares at $138.23 ($114,456)
Page 13 of 39 · 780 filings